Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial

Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial

Background A systemic proinflammatory state plays a central role in the development of heart failure with preserved ejection fraction. Low‐level transcutaneous vagus nerve stimulation suppresses inflammation in humans. We conducted a sham‐controlled, double‐blind, randomized clinical trial to examin...

Full description

Bibliographic Details
Main Authors: Stavros Stavrakis, Khaled Elkholey, Lynsie Morris, Monika Niewiadomska, Zain Ul Abideen Asad, Mary Beth Humphrey
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
autonomic modulation
heart failure with preserved ejection fraction
inflammation
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.023582

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.023582

Similar Items